Literature DB >> 21866061

Quantitative angiographic comparison with the OSIRIS program between the direct and indirect revascularization modalities in adult moyamoya disease.

Jae Seung Bang1, O-Ki Kwon, Jeong Eun Kim, Hyun-Seung Kang, Hyun Park, Sung Yun Cho, Chang Wan Oh.   

Abstract

BACKGROUND: Up-to-date, quantitative angiographic measurement of revascularization extent after bypass surgery has not been reported.
OBJECTIVE: To measure the extent of angiographic revascularization quantitatively 6 months postoperatively with the OSIRIS program (University Hospital of Geneva, version 3.1).
METHODS: A total of 75 bypass procedures were performed in 65 consecutive adult moyamoya disease patients, and 71 bypass surgeries in 61 adult moyamoya disease patients were studied 6 months postoperatively with angiography. We performed 5 different types of bypass surgeries: encephaloduroarteriosynangiosis (EDAS), superficial temporal artery-middle cerebral artery anastomosis (SMA), SMA with encephalomyosynangiosis (EMS), SMA with EDAS, and SMA with encephaloduroarteriomyosynangiosis (EDAMS). We also investigated single-photon emission computed tomography (SPECT) results after 6 months postoperatively and compared the angiographic revascularization extent with the SPECT results.
RESULTS: The mean values for the extent of revascularization among 5 different bypass surgeries were as follows: 32.4% for EDAS only, 57.4% for SMA only, 58.4% for SMA with EMS, 66.1% for SMA with EDAS, and 70.8% for SMA with EDAMS. There was a statistically significant difference in the extent of revascularization among the 5 surgical modalities (P = .000) and between the EDAS-only group and various SMA groups (P = .000). Statistical analysis between angiographic revascularization extent and SPECT results demonstrated significant statistical correlation (P = .000).
CONCLUSION: The extent of angiographic revascularization in adult moyamoya disease patients was highest in the SMA with EDAMS group and lowest in the EDAS-only group. In addition, angiographic revascularization extent was well correlated with the change in SPECT.

Entities:  

Mesh:

Year:  2012        PMID: 21866061     DOI: 10.1227/NEU.0b013e3182333c47

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  13 in total

1.  Hemispherical photoacoustic imaging of myocardial infarction: in vivo detection and monitoring.

Authors:  Jing Lv; Ya Peng; Shi Li; Zhide Guo; Qingliang Zhao; Xianzhong Zhang; Liming Nie
Journal:  Eur Radiol       Date:  2017-12-21       Impact factor: 5.315

2.  Moyamoya disease and moyamoya syndrome in Ireland: patient demographics, mode of presentation and outcomes of EC-IC bypass surgery.

Authors:  Ronan J Doherty; John Caird; Darach Crimmins; Peter Kelly; Sean Murphy; Christopher McGuigan; Niall Tubridy; Mary D King; Bryan Lynch; David Webb; Desmond O'Neill; Dominick J H McCabe; Peter Boers; Mary O'Regan; Joan Moroney; David J Williams; Simon Cronin; Mohsen Javadpour
Journal:  Ir J Med Sci       Date:  2020-06-19       Impact factor: 1.568

Review 3.  Surgical Treatment of Adult Moyamoya Disease.

Authors:  Si Un Lee; Chang Wan Oh; O-Ki Kwon; Jae Seung Bang; Seung Pil Ban; Hyoung Soo Byoun; Tackeun Kim
Journal:  Curr Treat Options Neurol       Date:  2018-05-28       Impact factor: 3.598

Review 4.  Progress in moyamoya disease.

Authors:  Shuling Shang; Da Zhou; Jingyuan Ya; Sijie Li; Qi Yang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Neurosurg Rev       Date:  2018-06-18       Impact factor: 3.042

5.  Larger Posterior Revascularization Associated with Reduction of Choroidal Anastomosis in Moyamoya Disease: A Quantitative Angiographic Analysis.

Authors:  T Funaki; A Miyakoshi; H Kataoka; J C Takahashi; Y Takagi; K Yoshida; T Kikuchi; Y Mineharu; M Okawa; Y Yamao; Y Fushimi; S Miyamoto
Journal:  AJNR Am J Neuroradiol       Date:  2022-08-25       Impact factor: 4.966

Review 6.  Moyamoya Disease: Treatment and Outcomes.

Authors:  Tackeun Kim; Chang Wan Oh; Jae Seung Bang; Jeong Eun Kim; Won-Sang Cho
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

7.  The Efficacy of Single Barrel Superficial Temporal Artery-middle Cerebral Artery Bypass in Treatment of Adult Patients with Ischemic-type Moyamoya Disease.

Authors:  Mahnjeong Ha; Chang Hwa Choi; Jae Il Lee; Seung Heon Cha; Sang Weon Lee; Jun Kyeung Ko
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2016-09-30

8.  The Efficacy of Surgical Treatment for the Secondary Prevention of Stroke in Symptomatic Moyamoya Disease: A Meta-Analysis.

Authors:  Cong Qian; Xiaobo Yu; Jianru Li; Jingyin Chen; Lin Wang; Gao Chen
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

Review 9.  The Targeted Bypass Strategy for Preventing Hemorrhage in Moyamoya Disease: Technical Note.

Authors:  Takeshi Funaki; Hiroharu Kataoka; Kazumichi Yoshida; Takayuki Kikuchi; Yohei Mineharu; Masakazu Okawa; Yukihiro Yamao; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-10-26       Impact factor: 1.742

10.  Quantitative analysis of revascularization in ischemic moyamoya disease via whole-brain computed tomography perfusion: A retrospective single-center study.

Authors:  Qingdong Han; Yabo Huang
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.